Loading...
The B cell mutator AID promotes B lymphoid blast crisis and drug-resistance in chronic myeloid leukemia
Chronic myeloid leukemia (CML) is induced by BCR-ABL1 and can be effectively treated for many years with Imatinib until leukemia cells acquire drug resistance through BCR-ABL1 mutations and progress into fatal B lymphoid blast crisis (LBC). Despite its clinical significance, the mechanism of progres...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931825/ https://ncbi.nlm.nih.gov/pubmed/19732723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2009.07.030 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|